Public filings / AKTS on Yahoo Finance (opens in a new tab)
AKTS: insider buying, 13F holders, analyst moves
Aktis Oncology Inc - US
A summary of public filings about Aktis Oncology Inc - US. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
6 of our 100 managers hold AKTS
Combined reported value $131.7M.
Holders among our 100 managers: 0 in Q3 2023, 6 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| RTW Investments | $51.3M | 0.44% | Unchanged |
| RA Capital | $42.4M | 0.37% | Trimmed |
| Baker Bros. Advisors | $32.1M | 0.16% | Unchanged |
| Soros Fund Management | $3.2M | 0.04% | Unchanged |
| Polen Capital | $2.0M | 0.02% | New |
| Tudor Investment | $690K | 0.00% | New |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.